Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Hammers

Showing results (151-160 of 174) with videos related to

Pageof 18
Sort By:
The Lancet. Digital Health|May 18, 2023
Profiling post-COVID-19 condition across different variants of SARS-CoV-2: a prospective longitudinal study in unvaccinated wild-type, unvaccinated alpha-variant, and vaccinated delta-variant populationsLiane S Canas, Erika Molteni, Jie Deng, et al.
The Lancet. Public Health|April 15, 2021
Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological studyMark S Graham, Carole H Sudre, Anna May, et al.
The Lancet. Child & Adolescent Health|August 6, 2021
Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2Erika Molteni, Carole H Sudre, Liane S Canas, et al.
BMJ Public Health|April 21, 2025
Social determinants of recovery from ongoing symptoms following COVID-19 in two UK longitudinal studies: a prospective cohort studyNathan J Cheetham, Vicky Bowyer, María Paz García, et al.
Brain Structure & Function|January 13, 2026
Inter-individual variability of neurotransmitter receptor and transporter density in the human brainJustine Y Hansen, Jouni Tuisku, Jarkko Johansson, et al.
Children (Basel, Switzerland)|May 28, 2022
Illness Characteristics of COVID-19 in Children Infected with the SARS-CoV-2 Delta VariantErika Molteni, Carole H Sudre, Liane Dos Santos Canas, et al.
Brain : a Journal of Neurology|December 1, 2025
Immune alterations in schizophrenia and the effects of a therapeutic antibody: a neuroimaging studyYuya Mizuno, Ines Carreira Figueiredo, Toby Pillinger, et al.
Lancet (London, England)|April 10, 2022
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID StudyCristina Menni, Ana M Valdes, Lorenzo Polidori, et al.
The Lancet Regional Health. Europe|July 13, 2022
Post-vaccination infection rates and modification of COVID-19 symptoms in vaccinated UK school-aged children and adolescents: A prospective longitudinal cohort studyErika Molteni, Liane S Canas, Kerstin Kläser, et al.
Eclinicalmedicine|September 1, 2023
The effects of COVID-19 on cognitive performance in a community-based cohort: a COVID symptom study biobank prospective cohort studyNathan J Cheetham, Rose Penfold, Valentina Giunchiglia, et al.
Pageof 18

Showing results (151-160 of 174) with videos related to

Sort By:
Pageof 18
The Lancet. Digital Health|May 18, 2023
Profiling post-COVID-19 condition across different variants of SARS-CoV-2: a prospective longitudinal study in unvaccinated wild-type, unvaccinated alpha-variant, and vaccinated delta-variant populationsLiane S Canas, Erika Molteni, Jie Deng, et al.
The Lancet. Public Health|April 15, 2021
Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological studyMark S Graham, Carole H Sudre, Anna May, et al.
The Lancet. Child & Adolescent Health|August 6, 2021
Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2Erika Molteni, Carole H Sudre, Liane S Canas, et al.
BMJ Public Health|April 21, 2025
Social determinants of recovery from ongoing symptoms following COVID-19 in two UK longitudinal studies: a prospective cohort studyNathan J Cheetham, Vicky Bowyer, María Paz García, et al.
Brain Structure & Function|January 13, 2026
Inter-individual variability of neurotransmitter receptor and transporter density in the human brainJustine Y Hansen, Jouni Tuisku, Jarkko Johansson, et al.
Children (Basel, Switzerland)|May 28, 2022
Illness Characteristics of COVID-19 in Children Infected with the SARS-CoV-2 Delta VariantErika Molteni, Carole H Sudre, Liane Dos Santos Canas, et al.
Brain : a Journal of Neurology|December 1, 2025
Immune alterations in schizophrenia and the effects of a therapeutic antibody: a neuroimaging studyYuya Mizuno, Ines Carreira Figueiredo, Toby Pillinger, et al.
Lancet (London, England)|April 10, 2022
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID StudyCristina Menni, Ana M Valdes, Lorenzo Polidori, et al.
The Lancet Regional Health. Europe|July 13, 2022
Post-vaccination infection rates and modification of COVID-19 symptoms in vaccinated UK school-aged children and adolescents: A prospective longitudinal cohort studyErika Molteni, Liane S Canas, Kerstin Kläser, et al.
Eclinicalmedicine|September 1, 2023
The effects of COVID-19 on cognitive performance in a community-based cohort: a COVID symptom study biobank prospective cohort studyNathan J Cheetham, Rose Penfold, Valentina Giunchiglia, et al.
Pageof 18